On the sun-drenched sands of Rio de Janeiro's world-famous Ipanema Beach, a retired Welsh rugby star and a local Brazilian activist recently stood together to confront a quiet, persistent crisis. Though separated by language and geography, both men share a common mission: dismantling the deep-seated social prejudice that continues to surround HIV, decades after the development of life-saving medical treatments.
Gareth Thomas, the former Welsh rugby icon who became a global champion for people living with HIV after disclosing his positive status in 2019, traveled to Brazil this summer to participate in the International AIDS Conference and promote his "Tackle HIV" advocacy campaign. His message of resilience and health directly mirrors the lived experience of Welton Gabriel, a 36-year-old event organizer from São Paulo who has spent more than a decade navigating the social fallout of his own diagnosis.
Thomas believes the root of the problem is a pervasive lack of public understanding regarding modern medicine. Many people remain entirely unaware that contemporary medications allow individuals with HIV to live long, healthy, and happy lives. According to Thomas, this ignorance breeds a damaging stereotype that those with the virus are weak, fragile, or frail. He emphasizes that he is none of those things, yet warns that the fear of being labeled often deters people from getting tested, seeking their results, or consistently taking their prescribed medication.
This reluctance to face the diagnosis has devastating real-world consequences in Brazil. National health data reveals that 27% of HIV-positive individuals in the country are only diagnosed and treated after their condition has already progressed to advanced AIDS. At this late stage, a severely compromised immune system leaves patients highly vulnerable to life-threatening opportunistic infections. In 2024, the most recent year for which official data is available, more than 9,000 people in Brazil died from AIDS-related complications.
For specialists like Beatriz Grinsztejn, a Brazilian infectious-diseases expert and former president of the International AIDS Society, these preventable deaths are deeply tragic. Grinsztejn notes that the tragedy lies in the fact that free tests and treatments are widely available through Brazil's public healthcare system, yet many individuals simply do not access them because of the social terror associated with the virus.
Welton Gabriel's personal journey illustrates the physical and emotional hurdles that patients face. Twelve years ago, Gabriel learned he had contracted a treatment-resistant strain of HIV, which he believes mutated after a sexual partner decided to abruptly stop taking their own medication. For seven grueling months, Gabriel's life hung in the balance as doctors struggled to control the infection. His viral load was exceptionally high, and the initial medication he was prescribed caused severe liver issues that turned his eyes yellow. Eventually, doctors switched him to the effective treatment regimen he remains on today.
Yet, the physical recovery was only the first battle. When Gabriel chose to share his diagnosis with close friends, many immediately cut off contact and refused to speak to him. Today, Gabriel channels that painful experience into activism, working with Barong, an organization that supports vulnerable communities across Brazil by offering mobile testing, educational resources, and information on HIV protection. He has come to realize that the hostility he faced was born out of profound fear.
In Brazil, a nation of approximately 214 million people, discrimination remains one of the most formidable obstacles to ending AIDS as a public health threat. The country has the largest population of people living with HIV in Latin America, totaling nearly 1.1 million. While the state-funded healthcare system provides free access to viral-suppressing medications that prevent transmission and enable normal lives, a study by UNAIDS Brazil indicates that more than half of all HIV-positive individuals in the country have experienced some form of discrimination, ranging from abandonment by friends and family to the loss of employment opportunities.
Gabriel observes that public perceptions of HIV in Brazil have remained largely frozen since 1990, the year the iconic Brazilian singer Cazuza died of AIDS at the age of 32. Cazuza's high-profile struggle with the debilitating illness brought HIV into household conversations across the country during the 1980s. However, because many Brazilians are unaware of how much medical science has advanced over the last three and a half decades, the singer's tragic decline remains the dominant cultural symbol of the virus, leaving many to still view an HIV diagnosis as an automatic death sentence. Gabriel recalls that when he first tested positive, his immediate reaction was to search Google, where the very first result he encountered was the story of Cazuza.
Even when individuals are diagnosed early, keeping them on their treatment plans is an ongoing challenge. Government statistics show that 82% of HIV-positive individuals in Brazil are actively taking antiretroviral drugs. While this is a substantial figure, it falls short of the United Nations' target of 95%. Activists note that patients often feel judged even by the healthcare professionals tasked with treating them. Fear that their confidential status might be illegally disclosed without consent erodes trust in the medical system. Gabriel explains that the daily pressure of being judged while taking medication causes many individuals to simply abandon their treatment altogether.
This climate of judgment is reinforced by a conservative shift in Brazilian society. Despite an international reputation for uninhibited sexuality, the domestic reality is highly conservative. Since 2014, federal, state, and municipal lawmakers have proposed more than 200 bills aimed at banning sex and gender education in schools. Two years ago, major cities saw protests erupt over a legislative proposal that sought to equate abortion with homicide.
Grinsztejn points out that this conservative atmosphere fosters high rates of violence against sexual minorities. Even Rio de Janeiro, widely promoted as a premier gay travel destination, suffers from severe homophobia and transphobia. The country has one of the highest rates of transgender murders globally, with the average life expectancy for trans individuals dropping to between 30 and 35 years due to violence, compared to the general national life expectancy of 76. This pervasive hostility feeds into the broader societal view of HIV as a disease linked to immorality, further driving discrimination.
The impact of this stigma is also heavily gendered, according to Fabiana de Oliveira, a 57-year-old activist with the National Network of Women Living with HIV. Diagnosed at the age of 26, de Oliveira was immediately abandoned by her fiancé of eight years, whom she suspected had transmitted the virus to her. His family even visited the hospital to verify her status before declaring she was no longer welcome in their home. Living in Catanduva, a small municipality in São Paulo state with a population of 100,000, she spent years dealing with intense societal and personal judgment.
De Oliveira explains that Brazilian women are traditionally expected to care for their husbands, children, and households, making it incredibly difficult to integrate an HIV diagnosis into their identity. This burden often leads women to blame themselves, severely impacting their mental and emotional health and causing many to withdraw into complete isolation.
The tragedy of this enduring stigma is compounded by the fact that Brazil is a global leader in HIV research and medical innovation. The country recently participated in clinical trials for lenacapavir, a twice-yearly injectable drug that has shown virtually 100% effectiveness in blocking HIV transmission. Following regulatory approval, Brazil is now conducting a large-scale, real-world study of the drug across multiple cities to determine how to best integrate it into public health systems. However, de Oliveira remains skeptical that such scientific breakthroughs can succeed without a parallel push for public education, noting that people are often far more terrified of how society will perceive them than they are of the virus itself.
Nevertheless, Gabriel's experience offers a glimmer of hope that education can gradually change minds. In the years following his diagnosis, he took the time to explain the realities of the virus to his family and friends, correcting their misconceptions about transmission and assuring them he was not going to die. Over time, some of the friends who had initially shunned him returned, proving that awareness can ultimately overcome fear.
That message resonates with another advocate: Welton Gabriel, a 36-year-old event organizer from Sao Paolo.
Gabriel sees this dynamic play out in daily life. "It's about being judged if you're seen taking your treatment each day, and the pressure that puts on people," he says. "If someone feels judged, a lot of times they will stop the treatment."
